Century Communit. Stock
Your prediction
Century Communit. Stock
The Century Communit. stock is trending slightly upwards today, with an increase of €0.50 (0.960%) compared to yesterday's price.
Pros and Cons of Century Communit. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Century Communit. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Century Communit. | 0.960% | -3.571% | 3.846% | -35.714% | -22.857% | - | - |
| Tri Pointe Homes | -1.410% | -2.778% | 3.704% | -28.934% | -18.129% | 60.920% | 102.899% |
| M/i Homes Inc. | -0.440% | -1.116% | 1.512% | -26.232% | -12.893% | 158.879% | - |
| Lgi Homes Inc. | 0.990% | -7.965% | 5.051% | -58.812% | -51.345% | -55.904% | - |
News
Why Century Aluminum Stock Soared Higher Today
Friday is turning out to be a great day to own shares of Century Aluminum (NASDAQ: CENX) -- one day after the metals producer reported earning nearly twice Wall Street's forecast for Q3.
Heading
Why Century Aluminum Stock Blasted Almost 13% Higher on Wednesday
Like the metal in which it specializes, Century Aluminum (NASDAQ: CENX) was solid on Wednesday. Investors piled into the stock following the initiation of coverage by one of America's top banks
Century Reports Flat Loss in Fiscal Q2
Century Therapeutics (NASDAQ:IPSC), an early-stage biotechnology company pioneering cell therapies using induced pluripotent stem cell (iPSC) technology, reported its second quarter 2025 financial